microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway
Metrics: PDF 4067 views | HTML 1481 views | ?
Yiyu Chen1,2,*, Jingwen Jiang1,*, Mengyang Zhao2,*, Xiaojun Luo1, Zixi Liang1,2, Yan Zhen2, Qiaofen Fu2, Xiaojie Deng1,2, Xian Lin1, Libo Li1, Rongcheng Luo1, Zhen Liu2,3, Weiyi Fang1,2
1Cancer Center, Traditional Chinese Medicine-Integrated Hospital of Southern Medical University, Guangzhou, PR China
2Cancer Research Institute, Southern Medical University, Guangzhou, PR China
3Department of Pathology, School of Basic Medicine, Guangzhou Medical College, Guangzhou, PR China
*These authors contributed equally to this work
Weiyi Fang, email: email@example.com
Zhen Liu, email: firstname.lastname@example.org
Rongcheng Luo, email: email@example.com
Keywords: miR-374a, CCND1, CRC, PI3K/AKT pathway, EMT
Received: September 05, 2015 Accepted: April 24, 2016 Published: May 12, 2016
microRNA-374a (miR-374a) exhibits oncogenic functions in various tumor types. Here we report that miR-374a suppresses proliferation, invasion, migration and intrahepatic metastasis in colon adenocarcinoma cell lines HCT116 and SW620. Notably, we detected that PI3K/AKT signaling and its downstream cell cycle factors including c-Myc, cyclin D1 (CCND1), CDK4 and epithelial-mesenchymal transition (EMT)-related genes including ZEB1, N-cadherin, Vimentin, Slug, and Snail were all significantly downregulated after miR-374a overexpression. Conversely, cell cycle inhibitors p21 and p27 were upregulated. Expression of E-cadherin was only decreased in HCT116, without any obvious differences observed in SW620 cells. Furthermore, luciferase reporter assays confirmed that miR-374a could directly reduce CCND1. Interestingly, when CCND1 was silenced or overexpressed, levels of pPI3K, pAkt as well as cell cycle and EMT genes were respectively downregulated or upregulated. We examined miR-374a levels by in situ hybridization and its correlation with CCND1 expression in CRC tumor tissues. High miR-374a expression with low level of CCND1 was protective factor in CRC. Together these findings indicate that miR-374a inactivates the PI3K/AKT axis by inhibiting CCND1, suppressing of colon cancer progression.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.